Serum prolactin as a correlate of clinical response to haloperidol

T. Van Putten, S. R. Marder, Jim Mintz

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The rise in serum prolactin concentration in patients treated with neuroleptic drugs is well documented, but attempts to relate this rise to clinical response have yielded conflicting results. These conflicting results could be explained by design flaws in those studies attempting to relate prolactin to clinical response. Seventy-three newly (re)admitted drug-free schizophrenic men were randomly assigned to receive haloperidol either 5, 10, or 20 mg daily for 4 weeks. Prolactin levels post-treatment were significantly (p < 0.02) related to global outcome by logistic regression. A serum prolactin level may be a useful guide to the lowest effective dose of haloperidol in newly treated schizophrenic men. Above a plasma prolactin level of ~ 30 ng/ml there was very little increase in response. Patients on the 5, 10, and 20 mg daily haloperidol doses had mean prolactin levels of 16, 32, and 34 ng/ml, respectively.

Original languageEnglish (US)
Pages (from-to)357-361
Number of pages5
JournalJournal of Clinical Psychopharmacology
Volume11
Issue number6
StatePublished - 1991
Externally publishedYes

Fingerprint

Haloperidol
Prolactin
Serum
Antipsychotic Agents
Logistic Models
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Serum prolactin as a correlate of clinical response to haloperidol. / Van Putten, T.; Marder, S. R.; Mintz, Jim.

In: Journal of Clinical Psychopharmacology, Vol. 11, No. 6, 1991, p. 357-361.

Research output: Contribution to journalArticle

@article{587b8afedad949ffbfacbb78a4994b1f,
title = "Serum prolactin as a correlate of clinical response to haloperidol",
abstract = "The rise in serum prolactin concentration in patients treated with neuroleptic drugs is well documented, but attempts to relate this rise to clinical response have yielded conflicting results. These conflicting results could be explained by design flaws in those studies attempting to relate prolactin to clinical response. Seventy-three newly (re)admitted drug-free schizophrenic men were randomly assigned to receive haloperidol either 5, 10, or 20 mg daily for 4 weeks. Prolactin levels post-treatment were significantly (p < 0.02) related to global outcome by logistic regression. A serum prolactin level may be a useful guide to the lowest effective dose of haloperidol in newly treated schizophrenic men. Above a plasma prolactin level of ~ 30 ng/ml there was very little increase in response. Patients on the 5, 10, and 20 mg daily haloperidol doses had mean prolactin levels of 16, 32, and 34 ng/ml, respectively.",
author = "{Van Putten}, T. and Marder, {S. R.} and Jim Mintz",
year = "1991",
language = "English (US)",
volume = "11",
pages = "357--361",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Serum prolactin as a correlate of clinical response to haloperidol

AU - Van Putten, T.

AU - Marder, S. R.

AU - Mintz, Jim

PY - 1991

Y1 - 1991

N2 - The rise in serum prolactin concentration in patients treated with neuroleptic drugs is well documented, but attempts to relate this rise to clinical response have yielded conflicting results. These conflicting results could be explained by design flaws in those studies attempting to relate prolactin to clinical response. Seventy-three newly (re)admitted drug-free schizophrenic men were randomly assigned to receive haloperidol either 5, 10, or 20 mg daily for 4 weeks. Prolactin levels post-treatment were significantly (p < 0.02) related to global outcome by logistic regression. A serum prolactin level may be a useful guide to the lowest effective dose of haloperidol in newly treated schizophrenic men. Above a plasma prolactin level of ~ 30 ng/ml there was very little increase in response. Patients on the 5, 10, and 20 mg daily haloperidol doses had mean prolactin levels of 16, 32, and 34 ng/ml, respectively.

AB - The rise in serum prolactin concentration in patients treated with neuroleptic drugs is well documented, but attempts to relate this rise to clinical response have yielded conflicting results. These conflicting results could be explained by design flaws in those studies attempting to relate prolactin to clinical response. Seventy-three newly (re)admitted drug-free schizophrenic men were randomly assigned to receive haloperidol either 5, 10, or 20 mg daily for 4 weeks. Prolactin levels post-treatment were significantly (p < 0.02) related to global outcome by logistic regression. A serum prolactin level may be a useful guide to the lowest effective dose of haloperidol in newly treated schizophrenic men. Above a plasma prolactin level of ~ 30 ng/ml there was very little increase in response. Patients on the 5, 10, and 20 mg daily haloperidol doses had mean prolactin levels of 16, 32, and 34 ng/ml, respectively.

UR - http://www.scopus.com/inward/record.url?scp=0025748680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025748680&partnerID=8YFLogxK

M3 - Article

C2 - 1770154

AN - SCOPUS:0025748680

VL - 11

SP - 357

EP - 361

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 6

ER -